2016 - Pharma Rep Focus

Sanofi prevails over Boehringer Ingelheim in legal battle over Zantac liabilities

Fierce Pharma

JUNE 20, 2023

When Sanofi made an asset swap with Boehringer Ingelheim in 2016, the French company acquired BI’s healthcare business, which included heartburn medicine Zantac. | In an asset swap with Boehringer in 2016, Sanofi gained U.S. marketing rights to the treatment.

Medicine

Medicine Healthcare Healthcare Marketing

Pfizer settles gender pay discrimination allegations at NYC headquarters

Fierce Pharma

OCTOBER 18, 2023

The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |

Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona

Fierce Pharma

SEPTEMBER 28, 2023

Bluebird and Lonza recently amended their production contract for the second time since the deal was announced in summer of 2016. As bluebird bio’s pricey gene therapy launches take flight, the company is boosting manufacturing capacity with Swiss CDMO Lonza.

Manufacturing

Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years

Fierce Pharma

JUNE 8, 2023

Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline | Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline in revenue every year since 2016.

Sales

Social medical: The social media buzz around ASCO 2016

pharmaphorum

JUNE 27, 2016

As a snapshot, 2014 saw 40,000 tweets and 140m+ impressions over the conference days, 2015 grew to 60,000 tweets and 250m+ impressions and the 2016 buzz is already louder and more plentiful than last year.

Media

Media Medical Pharma

Pharma is big business whose goal is to maximize shareholder value

World of DTC Marketing

JULY 9, 2021

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” ” From 2016 to 2020, compensation for the 14 companies’ top executives totaled $3.2 The drug industry is driven by profits, not by patient’s needs.

Pharma

Pharma FDA Leads Competition

The Top Sales Coaching Posts of 2016

The Brooks Group

NOVEMBER 10, 2016

Check out these popular sales coaching posts from 2016. Implementing an effective coaching program optimized for coaching quality and quantity can help grow revenue up to 16.7% So you probably agree that sales coaching is important, but what exactly does high quality sales coaching look like? .

Sales

Sales Sales Management Training Management

Sanofi licenses fourth NK cell engager from Innate Pharma

Pharmaceutical Technology

DECEMBER 19, 2023

Sanofi and Innate’s cancer collaboration agreement stretches back to 2016, with two of Sanofi’s NK cell engagers in clinical studies.

Pharma

Build a Top Performing Sales Team in 2016

The Brooks Group

NOVEMBER 2, 2015

The key to building an all-star team in 2016 is having the right people in the right positions, doing the work they were naturally wired for. As your team plans for growth in 2016, you’ll want to make sure you’re putting the right people in leadership positions. Promote the right people to leadership positions. Learn More.

Sales

Sales Sales territory Sales process Management

Walmart: Included Health Has Proved Its Value to Our Virtual Primary Care Program

MedCity News

OCTOBER 12, 2023

Walmart’s relationship with Included Health dates back to 2016 when its previous incarnation – Doctor on Demand – began providing virtual urgent care services to Walmart employees in three states.

Doctors

Study Finds Non-Opioid Pain Prescriptions Increased Following 2016 CDC Guideline

Pharmacy Times

JULY 22, 2022

The increase in prescriptions for non-opioid pain medications coincided with a significant drop in opioid prescribing over the same period.

Prescription

Prescription Medical

Gilead’s Vemlidy expands label to treat paediatric chronic HBV

Pharmaceutical Technology

MARCH 29, 2024

Vemlidy was first approved to treat adults with HBV in 2016. Its label was expanded in 2022 for use in patients 12 years and older.

Patients

Report: Primary Care Physicians Are Addressing Mental Health Concerns More Frequently

MedCity News

FEBRUARY 12, 2023

by 2016 and 2018, representing a 50% increase. The Health Affairs study found that in 2006, 10.7% of primary care visits addressed mental health concerns, compared 15.9%

Physicians

Report: Nurse Understaffing Is Becoming More Deadly for Patients

MedCity News

FEBRUARY 2, 2023

The percentage of respondents who know of a patient death being caused by nurses being assigned too many patients nearly doubled in the past seven years — from 22% in 2016 to 42% in 2023.

Patients

Patients Safety

Merck pays Moderna $250M to share equally in cancer vaccine for melanoma

MedCity News

OCTOBER 12, 2022

Moderna and Merck have been partners in the development of messenger RNA cancer vaccines since 2016. Merck is deepening the alliance by exercising an option that enables it to share equally in further work on a partnered cancer vaccine for melanoma.

Biopharma

Biopharma Pharma

Headspace Health advances equity of mental health through Shine acquisition

MedCity News

SEPTEMBER 9, 2022

Shine was first created in 2016 to provide mental health support to those in marginalized communities. Acquiring Shine will help Headspace Health improve its diversity, equity, inclusion and belonging efforts.

National uninsured rate reaches record low at 8%, HHS report shows

MedCity News

AUGUST 3, 2022

The previous record for the lowest national uninsured rate was 9% in 2016. . million people have gained healthcare coverage since 2020.

Healthcare

Healthcare Healthcare

We need evidence-based digital health

World of DTC Marketing

MARCH 6, 2022

A 2016 study reported that 259,000 digital health apps were available for consumers. A record number (296) of private digital health companies received venture funding in 2016, funding that totaled more than $4.2 Maybe, however, they should check with patients first. billion that year and approached $6 billion the following year.

Patients

Patients Doctors Leads FDA

Interoperability and Price Transparency in the 21st Century Cures Act: A Payer’s Perspective [Sponsored]

MedCity News

MARCH 6, 2023

A webinar sponsored by Intelligent Medical Objects March 16 will explore how payers are meeting the needs of the 2016 21st Century Cures Act when it comes to providing unfettered access to structured medical data for members.

Medical

Pennsylvania pharmacy owner must pay $4M for “no questions asked” oxycodone sales

MedCity News

OCTOBER 6, 2022

A neighborhood pharmacy owner was the largest purchaser of oxycodone among retail pharmacies in the entire state of Pennsylvania by 2016 and pled guilty to charges of conspiracy and fraud.

Retail

Retail Sales Biopharma

Report: Kids’ ED visits, inpatient admissions for mental health are increasing steadily

MedCity News

SEPTEMBER 12, 2022

children from 2016-21, according to new research. Mental health-related emergency department visits and inpatient hospital admissions have been rising among U.S. The report unveiled significant mental health utilization disparities between children covered by Medicaid and commercial insurance plans.

Insurance

Reviewing Consistency and Adequacy of Public vs. Commercial Health Insurance for American Children

PharmExec

DECEMBER 4, 2023

JAMA study evaluates differences in coverage types and potential from 2016-2021.

Insurance

Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment

Pharmaceutical Technology

AUGUST 3, 2023

Mithra has received €1.25m ($1.37m) from Fuji Pharma as part of a 2016 licence agreement involving Estelle for Japan and ASEAN regions.

Pharma

GAO Report on DTC/Medicare spending flawed

World of DTC Marketing

JUNE 18, 2021

1ne: Medicare Parts B and D and beneficiaries spent $560 billion on drugs from 2016 through 2018, $324 billion spent on advertised drugs. It was clearly written by somebody who knows the cost of DTC advertising without the value. So let’s look at the contents.

Government

Government Manufacturing Prescription Education

Latest Research from Clarify Health Institute Uncovers Key Trends and Diagnoses in Mental Health Crisis Among US Children and Young Adults

Clarify Health

MAY 18, 2023

million children and young adults up to 21 years old from 2016 to 2022. Last September, CHI released “The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016-2021,” which looked at mental health utilization among children with a diagnosed mental illness.

Media

Media Healthcare Healthcare Insurance

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

SEPTEMBER 9, 2021

Across America’s acute care hospitals, total revenues exceeded expenses by more than $64 billion in 2016, according to a Center for American Progress analysis. However, experiences among individual hospitals vary, and about one-quarter of both for-profit and not-for-profit hospitals lost money in 2016.

Healthcare

Healthcare Healthcare Government Insurance

A glimpse into public perception of mental health care in the United States

Clarify Health

MAY 30, 2023

According to its most recent research brief, “The Kids Are Not Alright: Mental Health Utilization Among Children and Young Adults, 2016-2022,” hospital admissions for mental illnesses rose 124% among children and young adults from 2016 – 2022.

Healthcare

Healthcare Healthcare Education Transportation

Incidence of Type 2 Diabetes Increased Significantly Following COVID-19 Pandemic

Pharmacy Times

SEPTEMBER 29, 2023

Investigators also found that rates of type 1 diabetes have been on the rise since 2016.

Moderna files lawsuits against Pfizer and BioNTech over mRNA technology

Pharmaceutical Technology

AUGUST 28, 2022

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, is said to have infringed patents filed by Moderna between 2010 and 2016 for its mRNA technology. This technology was vital for developing Spikevax, an mRNA Covid-19 vaccine of Moderna. 5 Omicron-targeting bivalent booster vaccine for Covid-19, mRNA-1273.222.

Food and Drug Administration

Food and Drug Administration Food Marketing Pharmaceutical

What’s Ahead in the Adalimumab Biosimilar Pipeline in Dermatology

Pharmacy Times

JULY 17, 2023

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

FDA

Four trends in HTA outcomes and timelines

Clarivate

NOVEMBER 11, 2021

The following article summarizes key findings from the latest CIRS R&D Briefing, Review of HTA outcomes and timelines in Australia, Canada and Europe 2016-202 0. This global reduction in the number of NAS appraisals had not been observed previously between 2016 to 2019, and so may be related to the COVID-19 pandemic.

Medicine

Medicine Marketing Pharmaceutical Patients

Filings buzz in pharmaceuticals: 65% increase in cloud computing mentions in Q1 of 2022

Pharmaceutical Technology

JULY 19, 2022

In total, the frequency of sentences related to cloud computing between April 2021 and March 2022 was 133% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.

Pharmaceutical

Nonpharmacologic Treatments Surpass Opioid Treatment for Patients with Chronic, Nonsurgical Pain

Pharmacy Times

NOVEMBER 11, 2022

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

Patients

Merck gets on board with Moderna cancer vaccine in $250m deal

pharmaphorum

OCTOBER 12, 2022

It is the first time that Merck has exercised an option in its collaboration with the mRNA vaccine specialist, first agreed in 2016 and expanded two years later to include additional candidates.

Patients

Patients Manufacturing Sales Management

Enhancing Patient Profiles to Support Personalized Care

PM360

APRIL 22, 2024

Published June 1, 2016. Accessed October 5, 2022 [link] com/2016/06/01/how-much-do-you-want-to-know-about-your- cancer/ Am Soc Clin Oncol Educ Book. 2020:40:1-9. Doi:10.1200/ EDBK_279767 3 Sekeres MA, Gilligan TD. How much do you want to know about your cancer?

Patients

Patients Education Healthcare Healthcare

A perfect storm for biotech stocks

World of DTC Marketing

FEBRUARY 1, 2022

It dropped more than 15% in 2016 and followed that up with a 44% rise in 2017. For starters, biotech stocks rarely have two bad years in a row. The last time the SPDR ETF suffered a drop of 15% or more was in 2018, and the fund followed it up with a 33% increase in 2019.

Food and Drug Administration

Food and Drug Administration FDA Pharmaceutical Food

EMA issues guidance amidst European medicine shortage

Pharmaceutical Technology

MAY 18, 2023

The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain. The group has been looking into solutions for improving the continuity of supply of human and veterinary medicines across Europe.

Medicine

Medicine Specialization Networking Manufacturing

EMA upgrades drug development innovation scheme to PRIME time

Pharmaceutical Technology

APRIL 5, 2023

The PRIME scheme, launched in March 2016, gives applicants a number of exclusive benefits to help reach regulatory approval. The announced changes to the PRIME scheme come after a five year analysis of the program in the 2016– 2021 period, following an initial two-year overview.

Medicine

Medicine Marketing

PBMs and insurers want your prescription money

World of DTC Marketing

JULY 27, 2022

Drug non-adherence cost the country at least $495 billion and contributed to over 275,000 premature deaths in 2016, according to a 2018 study in The Annals of Pharmacotherapy. When folks can’t afford their out-of-pocket prescription costs, many skip doses–and get sicker. It isn’t very likely.

Insurance

Insurance Prescription Medicine Medical

Moderna Files Suit Against Pfizer and BioNTech

PharmaTech

AUGUST 29, 2022

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.

Episode 83 – AI in Radiology and MedTech, a Researcher and Clinician’s Perspective with Paul Yi, MD

Medical Device Success

MARCH 13, 2022

In 2016, Geoffrey Hinton, PhD, famous for his work on artificial neural networks said, “It is quite obvious that we should stop training radiologists”. In 2016, Geoffrey Hinton, PhD, famous for his work on artificial neural networks said, “It is quite obvious that we should stop training radiologists”. They are as important as ever. .

Doctors

Doctors Training Medical Networking

Biogen: This train wreck was due

World of DTC Marketing

DECEMBER 10, 2021

When George Scangos resigned in 2016, he must have known that the future was bleak. Massive layoffs could be headed to Biogen due to the disappointing rollout of its Alzheimer’s drug Aduhelm that generated only a few million dollars in revenue over the past two quarters. Biogen went from being agile biotech to big pharma.

Training

Training Side effects Consulting Media

BioNTech’s RNA vaccine sparks potential in pancreatic cancer

Pharmaceutical Technology

MAY 11, 2023

In 2016, BioNTech and Genentech, a part of Roche signed an agreement to develop personalised mRNA therapies in oncology. At an 18-month follow-up, those who received the treatment were reported to have a longer recurrence-free survival, and the authors concluded that the T cell responses correlated with delayed disease recurrence.

Patients

Patients Leads

Merck and Moderna partner to develop and sell cancer vaccine

Pharmaceutical Technology

OCTOBER 14, 2022

In 2016, the companies entered a strategic partnership to develop novel messenger RNA (mRNA) based PCVs. German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV).

Pharmaceutical

Pharmaceutical Management Patients Medical

Sanofi prevails over Boehringer Ingelheim in legal battle over Zantac liabilities

Pfizer settles gender pay discrimination allegations at NYC headquarters

Trending Sources

Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona

Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years

Social medical: The social media buzz around ASCO 2016

Pharma is big business whose goal is to maximize shareholder value

The Top Sales Coaching Posts of 2016

Sanofi licenses fourth NK cell engager from Innate Pharma

Build a Top Performing Sales Team in 2016

Walmart: Included Health Has Proved Its Value to Our Virtual Primary Care Program

Study Finds Non-Opioid Pain Prescriptions Increased Following 2016 CDC Guideline

Gilead’s Vemlidy expands label to treat paediatric chronic HBV

Report: Primary Care Physicians Are Addressing Mental Health Concerns More Frequently

Report: Nurse Understaffing Is Becoming More Deadly for Patients

Merck pays Moderna $250M to share equally in cancer vaccine for melanoma

Headspace Health advances equity of mental health through Shine acquisition

National uninsured rate reaches record low at 8%, HHS report shows

We need evidence-based digital health

Interoperability and Price Transparency in the 21st Century Cures Act: A Payer’s Perspective [Sponsored]

Pennsylvania pharmacy owner must pay $4M for “no questions asked” oxycodone sales

Report: Kids’ ED visits, inpatient admissions for mental health are increasing steadily

Reviewing Consistency and Adequacy of Public vs. Commercial Health Insurance for American Children

Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment

GAO Report on DTC/Medicare spending flawed

Latest Research from Clarify Health Institute Uncovers Key Trends and Diagnoses in Mental Health Crisis Among US Children and Young Adults

Medicare savings won’t make a dent in healthcare costs

A glimpse into public perception of mental health care in the United States

Incidence of Type 2 Diabetes Increased Significantly Following COVID-19 Pandemic

Moderna files lawsuits against Pfizer and BioNTech over mRNA technology

What’s Ahead in the Adalimumab Biosimilar Pipeline in Dermatology

Four trends in HTA outcomes and timelines

Filings buzz in pharmaceuticals: 65% increase in cloud computing mentions in Q1 of 2022

Nonpharmacologic Treatments Surpass Opioid Treatment for Patients with Chronic, Nonsurgical Pain

Merck gets on board with Moderna cancer vaccine in $250m deal

Enhancing Patient Profiles to Support Personalized Care

A perfect storm for biotech stocks

EMA issues guidance amidst European medicine shortage

EMA upgrades drug development innovation scheme to PRIME time

PBMs and insurers want your prescription money

Moderna Files Suit Against Pfizer and BioNTech

Episode 83 – AI in Radiology and MedTech, a Researcher and Clinician’s Perspective with Paul Yi, MD

Biogen: This train wreck was due

BioNTech’s RNA vaccine sparks potential in pancreatic cancer

Merck and Moderna partner to develop and sell cancer vaccine

Stay Connected